LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
7.22
-0.02 (-0.28%)
Nov 20, 2024, 4:00 PM EST - Market closed
LifeStance Health Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 1,206 | 1,056 | 859.54 | 667.51 | 377.22 | 212.52 |
Revenue Growth (YoY) | 20.08% | 22.82% | 28.77% | 76.96% | 77.50% | - |
Cost of Revenue | 829.82 | 753.57 | 622.53 | 466 | 242.9 | 143.09 |
Gross Profit | 376.28 | 302.1 | 237.02 | 201.51 | 134.32 | 69.43 |
Selling, General & Admin | 351.08 | 343.27 | 373.43 | 431.13 | 87.84 | 48.1 |
Operating Expenses | 429.57 | 423.7 | 442.63 | 485.26 | 118.88 | 54.19 |
Operating Income | -53.3 | -121.61 | -205.61 | -283.76 | 15.44 | 15.24 |
Interest Expense | -22.67 | -21.22 | -19.93 | -38.91 | -22.13 | -5.41 |
Other Non Operating Income (Expenses) | -0.12 | -0.11 | -0.22 | -0.26 | -0.28 | - |
EBT Excluding Unusual Items | -76.09 | -142.94 | -225.75 | -322.92 | -6.97 | 9.83 |
Merger & Restructuring Charges | -10.81 | -15.69 | -3.05 | -6.07 | -37.18 | -2.19 |
Legal Settlements | -2.82 | -51.03 | -0.85 | - | - | - |
Other Unusual Items | 2.67 | 3.08 | -3.08 | -4.12 | -0.25 | 0.23 |
Pretax Income | -87.05 | -206.58 | -232.73 | -333.11 | -44.41 | 7.88 |
Income Tax Expense | 8.24 | -20.32 | -17.17 | -25.91 | -6.34 | 2.21 |
Net Income | -95.29 | -186.26 | -215.56 | -307.2 | -38.07 | 5.67 |
Preferred Dividends & Other Adjustments | - | - | - | 36.75 | 248.3 | 64.57 |
Net Income to Common | -95.29 | -186.26 | -215.56 | -343.95 | -286.37 | -58.9 |
Shares Outstanding (Basic) | 377 | 367 | 355 | 328 | 302 | 0 |
Shares Outstanding (Diluted) | 377 | 367 | 355 | 328 | 302 | 0 |
Shares Change (YoY) | 3.69% | 3.43% | 8.47% | 8.33% | 999949.62% | - |
EPS (Basic) | -0.25 | -0.51 | -0.61 | -1.05 | -0.95 | -1948.40 |
EPS (Diluted) | -0.25 | -0.51 | -0.61 | -1.05 | -0.95 | -1948.40 |
Free Cash Flow | 35.06 | -57.4 | -26.47 | -85.07 | -46.6 | 2.73 |
Free Cash Flow Per Share | 0.09 | -0.16 | -0.07 | -0.26 | -0.15 | 90.43 |
Gross Margin | 31.20% | 28.62% | 27.57% | 30.19% | 35.61% | 32.67% |
Operating Margin | -4.42% | -11.52% | -23.92% | -42.51% | 4.09% | 7.17% |
Profit Margin | -7.90% | -17.64% | -25.08% | -51.53% | -75.92% | -27.72% |
Free Cash Flow Margin | 2.91% | -5.44% | -3.08% | -12.74% | -12.35% | 1.29% |
EBITDA | 25.2 | -41.17 | -136.41 | -229.62 | 46.48 | 21.34 |
EBITDA Margin | 2.09% | -3.90% | -15.87% | -34.40% | 12.32% | 10.04% |
D&A For EBITDA | 78.5 | 80.44 | 69.2 | 54.14 | 31.05 | 6.1 |
EBIT | -53.3 | -121.61 | -205.61 | -283.76 | 15.44 | 15.24 |
EBIT Margin | -4.42% | -11.52% | -23.92% | -42.51% | 4.09% | 7.17% |
Effective Tax Rate | - | - | - | - | - | 28.01% |
Source: S&P Capital IQ. Standard template. Financial Sources.